Megan Hutcherson
Medical · Norman, OKNPI 1881793859
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,289 of the $6,983 with a category attached, or 61.4%. 26 manufacturers reported payments, led by Medtronic at 44.8% of the total. Reporting peaked in 2024 at $3,865 and has fallen 83.0% since, to $658 in 2025. Among medical clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $38.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Amgen$357
- Novo Nordisk$330
- Abbott$242
- Novartis$200
- plus $1K from 20 others
What the payments were for
- Travel & lodging$2,69439%
- Food & beverage$4,28961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 45 | $3,125 |
| Boston Scientific | 9 | $1,549 |
| Amgen | 28 | $357 |
| Novo Nordisk | 17 | $330 |
| Abbott | 7 | $242 |
| Novartis | 11 | $200 |
| Merck | 12 | $182 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $173 |
| Johnson & Johnson | 8 | $130 |
| Spinal Simplicity, LLC | 1 | $91 |
| Boehringer Ingelheim | 5 | $79 |
| AstraZeneca | 5 | $70 |
| Esperion Therapeutics, Inc. | 4 | $66 |
| Philips North America LLC | 2 | $65 |
| Baxter Healthcare | 3 | $54 |
| Edwards Lifesciences | 1 | $52 |
| Bridgebio Pharma, Inc. | 1 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $30 |
| Pfizer | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GSK | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,983 in reported general payments places this provider in the 90th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 23 | $302 |
Paid to pharmacies, not to this prescriber.
Other medical in Norman
- Clint HowellNorman$10K
- Madison KearneyNorman$6K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
- Katelyn PuryearOklahoma City$22K
- Tara LinvilleTulsa$19K
- Debra OdomTulsa$17K
- Donna BowersTuttle$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.